It’s Never Been Easier™
MED-EL Announces RONDO 2: A True Revolution in Cochlear Implants

RONDO 2 is the first cochlear implant audio processor that can be charged wirelessly. This ground-breaking new design takes away the need for disposable batteries, making RONDO 2 the easiest-to-use audio processor ever made.



September 15, 2017 — (Innsbruck, Austria) — MED-EL, leading provider of hearing loss solutions, has launched the first cochlear implant audio processor with wireless charging.

Powering up RONDO 2 couldn’t be easier. Users simply have to place it on the charging pad and it will charge automatically. Each 4 hour charge gives an exceptional 18 hours of battery life—in other words, a full day of hearing from one overnight charge.

This simple design means that for the first time, cochlear implant users will not have to deal with the hassles of changing batteries or adjusting their processor. They can just put on RONDO 2 each morning, and then forget about it for the rest of the day.

“We’re so used to charging our mobile devices at home overnight,” says Gregor Dittrich, Director of Product Management at MED-EL. “You charge your phone and tablet in this way, so why not your audio processor? It’s the next logical step for cochlear implants and we’re so excited to be pioneering the way forward”.

RONDO 2’s single-unit design is sleeker and more streamlined than ever before. It is perfect to wear with glasses or hide completely under hair. With the interchangeable Design Covers, users can also make RONDO 2 blend in with their natural hair colour, or match their own unique style.

And of course, with waterproof covers, and Bluetooth accessories for easy connectivity with phones—RONDO 2 is ideal for a busy, modern lifestyle.

RONDO 2 will be available from the beginning of 2018, depending on country. Visit rondo2.medel.com for more information.


About MED-EL

MED-EL Medical Electronics is a leading provider of hearing loss solutions worldwide, and offers the broadest portfolio of hearing systems. The company was founded by Austrian scientists and industry pioneers Ingeborg and Erwin Hochmair, who in 1977 together developed the world’s first microelectronic, multichannel cochlear implant. In 1990, they laid the foundation for the successful growth of the company when they hired their first employees. To date, the privately held company has over 1,800 employees around the world.

The cochlear implant was the first, and remains the only, replacement of a human sense—the sense of hearing. To treat the various types and degrees of hearing loss, MED-EL offers the widest range of hearing loss solutions, including cochlear, middle ear and bone conduction systems, as well as a system for combined electric and acoustic stimulation.

MED-EL’s mission is to overcome hearing loss as a barrier to communication and quality of life. Individuals in more than 115 countries have had their hearing restored with a MED-EL hearing loss solution.


Responsible for the content

MED-EL Medical Electronics
Fürstenweg 77a
6020 Innsbruck
Austria

Press contact

Patrick D`Haese
T: +43 5 7788-0
E: press@medel.com
www.medel.com



CE Mark is pending.

© 2017 MED-EL